V2M-13563-94408
2 vaccinations
2 coded responses
7 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 085 / NJ
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
- 2021-03-31
- 2021-04-01
- 2021-04-05
-
2021-04-08
Survey response — day 7, dose 1MedDRA: Nasal congestion — Feeling: FairFree text: Congested noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-22
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Symptoms were yesterday 4/21/21MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech |
Free text
Release 7 — day 7, dose 1
Systemic reaction (other): Congested nose
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Symptoms were yesterday 4/21/21
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release